MedTrace Logo

Mesh Ablator Versus Cryoballoon Pulmonary Vein Ablation of Symptomatic Paroxysmal Atrial Fibrillation

NCT01061931 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 108

Last updated 2014-06-24

No results posted yet for this study

Summary

The purpose of this prospective randomized single-center trial is to compare efficiency and safety of two pulmonary vein ablation systems in patients with symptomatic paroxysmal atrial fibrillation using the Arctic Front® versus the HD Mesh Ablator® catheter.

Conditions

  • Symptomatic Paroxysmal Atrial Fibrillation

Interventions

PROCEDURE

Arctic Front® catheter vs. HD Mesh Ablator® catheter

Pulmonary vein ablation in patients with symptomatic paroxysmal atrial fibrillation using the Arctic Front® catheter versus the HD Mesh Ablator® catheter

Sponsors & Collaborators

  • German Federal Ministry of Education and Research

    collaborator OTHER_GOV

  • Charite University, Berlin, Germany

    lead OTHER

Principal Investigators

  • Alexander Schirdewan, MD · Department of Cardiology, Charité - University Medicine Berlin, Germany.

  • Jochen B Fiebach, MD · Center for Stroke Research Berlin

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-03-31
Primary Completion
2010-11-30
Completion
2011-11-30

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01061931 on ClinicalTrials.gov